Journal profile · Cardiac & Cardiovascular Systems
Journal of Cardiovascular Pharmacology and Therapeutics
ISSN 1074-2484 · eISSN 1940-4034 · SAGE Publications Ltd · UNITED STATES · Quarterly · Founded 1996
Journal of Cardiovascular Pharmacology and Therapeutics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.84; fully open access; APC about USD 1,325; review 6–12 weeks (community reports); community-reported acceptance: fairly easy; 19 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Cardiovascular Pharmacology and Therapeutics is published by SAGE Publications Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cardiac electrophysiology and arrhythmias, Cardiac Ischemia and Reperfusion and Atrial Fibrillation Management and Outcomes, together about 28.3% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) provides clinical and basic/translational investigators with novel insights into state-of-the-art therapeutic approaches for cardiovascular diseases. From … | View full journal description
From the journal's Aims & Scope
Research area (LetPub): Cardiac & Cardiovascular Systems
Editor-in-chief Josip A. BorovacPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 50, Germany 6, Italy 4, Austria 4, United Kingdom 3 (91 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cardiac electrophysiology and arrhythmiasMedicine11.4%
- Cardiac Ischemia and ReperfusionMedicine9%
- Atrial Fibrillation Management and OutcomesMedicine7.8%
- Lipoproteins and Cardiovascular HealthMedicine6.8%
- Heart Failure Treatment and ManagementMedicine6.2%
- Antiplatelet Therapy and Cardiovascular DiseasesMedicine6%
- Cardiac Arrhythmias and TreatmentsMedicine4.4%
- Cardiovascular Function and Risk FactorsMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.84LetPub ·
- Impact factor (publisher)
- 2.9Publisher website ·
- 5-year impact factor (publisher)
- 2.4Publisher website ·
- CiteScore 2026-06
- 5.6LetPub ·
- SJR 2026-06
- 0.83LetPub ·
- SNIP 2026-06
- 0.99LetPub ·
- h-index
- 44LetPub ·
- h-index
- 68OpenAlex ·
- i10-index
- 843OpenAlex ·
- 2-year mean citedness
- 1.92OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 17LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
Articles by year OpenAlex count · 1,411 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 23 | 23 | 1 |
| 2025 | 19 | 19 | 32 |
| 2024 | 18 | 18 | 82 |
| 2023 | 28 | 28 | 282 |
| 2022 | 34 | 34 | 418 |
| 2021 | 43 | 16 | 606 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 11.3%Publisher website ·
- Submission to first decision
- 6 daysPublisher website ·
- Acceptance to publication
- 25 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,325 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 1,325 | — | — | |
| Publisher website | USD 2,800 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Manuscript length
- ≤ 6,000 words
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Required
- Graphical abstract
- Optional
- Cover letter
- Required
- Not considered
- Case reports; Studies of herbal remedies
Article types accepted13, with length limits
- case reportView our Special Collections currently accepting submissions. JCPT publishes both original clinical studies and original preclinical investigations with clear t…Length not stated
- commentaryView our Special Collections currently accepting submissions. JCPT publishes both original clinical studies and original preclinical investigations with clear t…Length not stated
- correspondencesCorrespondencesLength not stated
- editorialView our Special Collections currently accepting submissions. JCPT publishes both original clinical studies and original preclinical investigations with clear t…Length not stated
- letterView our Special Collections currently accepting submissions. JCPT publishes both original clinical studies and original preclinical investigations with clear t…main text ≤ 1,000 words
- letters to the editorView our Special Collections currently accepting submissions. JCPT publishes both original clinical studies and original preclinical investigations with clear t…Length not stated
- meta-analysisView our Special Collections currently accepting submissions. JCPT publishes both original clinical studies and original preclinical investigations with clear t…Length not stated
- research articleView our Special Collections currently accepting submissions. JCPT publishes both original clinical studies and original preclinical investigations with clear t…main text ≤ 6,000 words
- research articlesJCPT accepts the following article types: Research ArticlesLength not stated
- reviewView our Special Collections currently accepting submissions. JCPT publishes both original clinical studies and original preclinical investigations with clear t…Length not stated
- review articleView our Special Collections currently accepting submissions. JCPT publishes both original clinical studies and original preclinical investigations with clear t…main text ≤ 7,500 words
- review articlesReview ArticlesLength not stated
- systematic reviewView our Special Collections currently accepting submissions. JCPT publishes both original clinical studies and original preclinical investigations with clear t…Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Author contributions
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. As a condition of publication authors are required to: Share your research data in a relevant public data repository Include a data availability statement. This sho…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- Open access Publishing fees and open access
Journal of Cardiovascular Pharmacology and Therapeutics is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the c…
Source ↗Publisher website ·- Peer review Peer review policy
Single anonymized review Model summary
The following summary describes the peer review process for this journal: Identity transparency: Single Anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SAGE Publications Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1996
- ISSN
- 1074-2484
- Electronic ISSN
- 1940-4034
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Cardiovascular Pharmacology and Therapeutics
What CAS zone is Journal of Cardiovascular Pharmacology and Therapeutics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Cardiovascular Pharmacology and Therapeutics is in Zone 4 of Medicine, and in Zone 3 of the minor category Pharmacology & Pharmacy / Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Cardiovascular Pharmacology and Therapeutics?
The latest impact factor listed by LetPub is 2.84; CiteScore 5.6, h-index 68.
How long does peer review take at Journal of Cardiovascular Pharmacology and Therapeutics?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 11.3%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Cardiovascular Pharmacology and Therapeutics?
According to the journal's author guidelines: Manuscript length: ≤ 6,000 words; Reference style: AMA; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Required; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Cardiovascular Pharmacology and Therapeutics based?
Of the 91 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (50), Germany (6) and Italy (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Cardiovascular Pharmacology and Therapeutics?
According to LetPub and DOAJ records, Journal of Cardiovascular Pharmacology and Therapeutics is indexed in SCIE, Scopus and DOAJ.
Is Journal of Cardiovascular Pharmacology and Therapeutics open access, and what is the APC?
Journal of Cardiovascular Pharmacology and Therapeutics is a fully open-access journal. APC about USD 1,325.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .